Docace911
@Docace911
Followers
570
Following
2K
Media
143
Statuses
2K
Steven J Chmura MD PhD. Xbox aficionados and oncologist studying #ADscopal and #ABscopal along with #oligometastases., @Halo Infinite Rank Gold2
iPhone: 41.892258,-87.614243
Joined January 2009
Congrats!!!!!!!!!!!!!!!!!!!!!!!!!
0
0
3
Happy to present our work led by excellent PGY4 @ConnorLynchMD on a pooled analysis of liver SBRT and immunotherapy in patients with polymetastatic disease treated on three phase 1 trials @UCCancerCenter. https://t.co/DC53PgKgkC We show that:
2
11
36
In our #AskAScientist series on promising areas of cancer research for those starting their scientific careers, Ludwig @UChicagoMed’s Ralph Weichselbaum highlights bioinformatic analysis as a key skill for future researchers.
2
13
23
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy - ScienceDirect Congrats @rweichselbaum @Docace911 and team!! #radonc
0
2
14
Wonderful night celebrating our talented residents at our end of year graduation dinner. Looking forward to following the careers of a truly amazing class @jarah_md @RohanKatipally @grozomah
@UChicagoRadonc
2
7
30
Celebrating our wonderful clinical trial staff who make cutting edge research possible and accessible to our patients !! @UChicagoRadonc
@UCCancerCenter @Docace911 @jarah_md @RohanKatipally
1
5
13
@jasonlukemd @Docace911 @UPMCHillmanCC @PittDeptofMed @UCCancerCenter @Ludwig_Cancer @radoncadonk1 @RadiumSociety @ASTRO_org @jclinicalinvest @mkorps42 There definitely is a bad scopal in some cases! Coming soon, May 25! This is great work however, when did parameters to see who will get immune stimulation or inhibitors
0
1
3
With @Docace911 we present our dogma challenging #RadOnc & #immunotherapy manuscript showing safety & prelim efficacy of partial tumor irradiation with anti-PD1. In contrast w aBscopal, we suggest an aDscopal effect where IO enhances local #radiation. https://t.co/VNVhZGTr31
3
9
41
One day we will learn that overworking people is not beneficial. We will fix being short-staffed before it becomes an unsustainable problem. Until then, my vacation is worth gold.
In toxic cultures, you have to burn out to earn a break. Time off is how you recover. In decent cultures, you take a break when you're low on gas. Time off is how you refuel. In healthy cultures, you're expected to take regular breaks. Time off is encouraged to sustain energy.
1
6
21
Dr. Julia White will discuss the NRG-BR007 DEBRA Trial today during a poster presentation at #SABCS22. This #clinicaltrial is looking at reducing the use of breast radiation after lumpectomy for people with low-risk, early-stage #breastcancer. Learn more: https://t.co/0wF3y0fjjW
1
3
10
📢Excited that our new IIT evaluating ctDNA response-adaptive IO-based therapy in #headandneckcancer now open to accrual @UCCancerCenter! Thank you to @CancerRF for the support! 🧑🔬🔬 https://t.co/rPs7jLXhfm
0
6
24
Two fantastic papers published this week in @NatureCancer & @NatureGenet by @SeanPitroda and his team. This work demonstrates the need for concurrent radiation and immunotherapy for certain mNSCLC patients. @UChicagoMed @UCCancerCenter
@lfspurr
https://t.co/YP9szx4evx
0
4
11
Remember the NULL: fun to respond to this commentary with my good colleague @Dr_Julia_White and in my role as Hand to the King @IBCradiation @NRGonc @UChicagoBreast Reply to J. Widder
ascopubs.org
1
1
7
📣 OUT NOW @NatureGenet 📰 Tumor aneuploidy predicts survival following immunotherapy across multiple cancers 🧑🏿🤝🧑🏽 @SeanPitroda and team 👇🏽 https://t.co/qGxur8xCXR
0
11
32
I am pleased to share our recent work published in @NatureCancer:
3
16
61
Extreme gratitude to my colleagues who contributed to this work @lfspurr @rweichselbaum @eevokes @MengjieChen6 @JPatelMD @max_diehn @Docace911 and funding from @Ludwig_Cancer @LUNGevity @UCCancerCenter @UChicagoMed @UChicagoRadonc
3
5
17